WIPO trademark

RETICEP

RegisteredWIPOClass 5

"RETICEP" is a trademark owned by Kyoto Drug Discovery & Development Co., Ltd., filed at the WIPO on July 27, 2022. It is registered and covers class 5 (Pharmaceuticals).

View Kyoto Drug Discovery & Development Co., Ltd. portfolioGet this data via the API
RETICEP
Trademark as filed with the WIPO
Status
Registered
Filed
July 27, 2022
Registered
Not yet
Expires
July 27, 2032
Application no.
Not recorded
Registration no.
1682320
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
1 class
Ownership

Who owns RETICEP

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Kyoto Drug Discovery & Development Co., Ltd.

Japan

3 trademarks in the portfolioView company

Representative

YAMADA Iichiro

Goods and services

What the mark covers

The products and services RETICEP is filed for, grouped by Nice class.

  • Ophthalmologic preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for orthopaedic purposes; pharmaceutical preparations for use in urology; pharmaceutical preparations for treating respiratory diseases; pharmaceutical agents affecting digestive organs; pharmaceutical preparations for activating cellular function; cytostatics for pharmaceutical purposes; pharmaceutical preparations and substances.

FAQ

About RETICEP

Who owns the trademark "RETICEP"?

The WIPO trademark "RETICEP" is owned by Kyoto Drug Discovery & Development Co., Ltd.

What is the status of "RETICEP"?

Its status at the WIPO is: registered.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RETICEP and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_5f585f58-a3e0-4920-9bec-b51f586fc371
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_5f585f58-a3e0-4920-9bec-b51f586fc371",
  "object": "trademark",
  "mark_text": "RETICEP",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2022-07-27",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Kyoto Drug Discovery & Development Co., Ltd.",
      "entity_id": "ent_019ebb75-9ce1-730e-83ec-d21e9aed8fd9"
    }
  ]
}